Johannes Streffer
Plus aucun poste en cours
Historique de carrière de Johannes Streffer
Anciens postes connus de Johannes Streffer
Sociétés | Poste | Début | Fin |
---|---|---|---|
AC IMMUNE SA | Chief Tech/Sci/R&D Officer | 11/01/2021 | 30/09/2023 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - | - |
UCB Biopharma SRL
UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The private company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Corporate Officer/Principal | - | - |
Formation de Johannes Streffer
Eberhard Karls Universität Tübingen | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 2 |
Suisse | 2 |
Allemagne | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Entreprise privées | 2 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
UCB Biopharma SRL
UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The private company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Distribution Services |
- Bourse
- Insiders
- Johannes Streffer
- Expérience